Physician profile

Christopher W Boyes

Vascular Surgery · Palm Beach Gardens, FL

NPI 1871810440

$58,907.81

in general payments reported to CMS, 2019-2025

30 companies · $4,862 in 2025

The $4,862 reported for 2025 was more than what 84% of Vascular Surgery providers received nationally (typical 2025 total: $927).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,426.95
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$3,600.00
Travel and Lodging$2,048.29

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $40,988.56 2019-2025 Indigo System, Penumbra System, Ruby Coil
Endologix LLC $3,720.75 2020-2025 Torus Stent Graft System, Endocross Device, Afx2 Bifurcated Endograft System
Cook Medical LLC $3,542.09 2019-2025 Icast Covered Stent System, 6mmx22mmx120cm, Zilver Ptx, Zilver Vena
Cardiovascular Systems INC. $2,755.51 2019-2022
Silk Road Medical, INC. $1,957.49 2019-2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Philips North America LLC $1,234.46 2019-2023
Medtronic Vascular, INC. $877.77 2019-2020
Bolton Medical INC $618.42 2019-2025 Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System
W. L. Gore & Associates, INC. $543.10 2019-2024 Gore Viabahn Vbx Balloon Expandable Endo
Medtronic, INC. $529.64 2021-2025 Venaseal, Closurefast, Endurant Iis
Boston Scientific Corporation $457.23 2020-2025 Varithena Administration Pack
Janssen Pharmaceuticals, INC $263.46 2021-2022
Shockwave Medical, INC $245.87 2019-2025
Abbott Laboratories $205.78 2019-2025 Diamondback Peripheral
Atrium Medical Corporation $198.67 2020
Show all 30 companies
CompanyGeneral paymentsYearsTop products
Cvrx, INC. $145.64 2024 Barostim Neo System
Ekos Corporation $139.45 2019
Getinge USA Sales, LLC $137.27 2019-2020
Tactile Systems Technology INC $104.58 2020-2025 Flexitouch Plus, Nimbl, Entre Plus
Janssen Scientific Affairs, LLC $53.03 2022
Lemaitre Vascular, INC. $34.98 2020
Terumo Medical Corporation $26.26 2025 Angio-Seal
Atricure, INC. $24.42 2025 Atricure Cryoice Cryosphere Cryoablation System
Cordis US Corp. $22.52 2021
Teleflex LLC $22.08 2022
Angiodynamics, INC. $16.35 2020
Pfizer INC. $16.17 2023
Urgo Medical North America, LLC $13.64 2024 Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap
Sirtex Medical INC $6.68 2024 Lava Les (Liquid Embolic System)
Asahi Intecc USA, INC. $5.94 2024 Peripheral Vascular

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher W Boyes

$58,907.81

in general payments reported 2019-2025

Years
2019-2025
Top company
Penumbra, INC.
Context
The $4,862 reported for 2025 was more than what 84% of Vascular Surgery providers received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/388080/christopher-w-boyes

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.